This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Bevacizumab and sunitinib: risk of osteonecrosis of the jaw. Drug Safety Update 4: [3 pages], No. 6, Jan 2011
About this article
Cite this article
In their January 2011 Drug Safety Update, the UK MHRA warns that treatment with either bevacizumab [Avastin] or sunitinib [Sutent]. React. Wkly. 1335, 3 (2011). https://doi.org/10.2165/00128415-201113350-00007
- Public Health